Vanguard Investments Australia
CNMD icon

Vanguard Investments Australia’s CONMED CNMD Stock Holding History

Vanguard Investments Australia’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$277K Buy
8,468
+1,800
+27% +$64.8K ﹤0.01% 1964
2026
Q1 		$236K Buy
+6,668
New +$271K ﹤0.01% 1960

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Vanguard Investments Australia's CNMD Position: Q2 2026 in Review

Vanguard Investments Australia increased its CONMED (CNMD) stake by 27% in Q2 2026, buying an estimated $64.8K and bringing the position to 8,468 shares worth $277K. The position accounts for ﹤0.01% of the portfolio, ranked #1964.

Vanguard Investments Australia first reported a position in CNMD in Q1 2026 and has held it in 2 quarters since. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Vanguard Investments Australia held 8,468 shares of CONMED worth $277K as of Q2 2026.
  • Vanguard Investments Australia bought 1,800 CONMED shares in Q2 2026, an estimated $64.8K.
  • CONMED made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #1964 holding.
  • Vanguard Investments Australia first reported a position in CONMED in Q1 2026 and has held it in 2 quarters since.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.